Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-73.87%Return on Assets
VS
Market
Sector
Industry
History
$ 7.67Close
$ 4.25 - $ 27.58 52-Week Range
Ticker Information
Ticker
LYRACompany Name
LYRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYRA THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYRA - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 52.57M | $ -38.84M | -73.87% |
| 3/31/2025 | $ 56.32M | $ -79.53M | -141.22% |
| 12/31/2024 | $ 66.35M | $ -93.44M | -140.83% |
| 9/30/2024 | $ 78.76M | $ -97.61M | -123.94% |
| 6/30/2024 | $ 94.58M | $ -101.39M | -107.2% |
| 3/31/2024 | $ 141.53M | $ -68.88M | -48.67% |
| 12/31/2023 | $ 142.6M | $ -62.68M | -43.96% |
| 9/30/2023 | $ 120.58M | $ -61.76M | -51.22% |
| 6/30/2023 | $ 125.67M | $ -60.87M | -48.44% |
| 3/31/2023 | $ 93.87M | $ -59.62M | -63.52% |
Key Performance Insights, Last 5 Years
- LYRA THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at 0%.
- Over the past 5 years, LYRA THERAPEUTICS INC's average ROA has been -68.59%.
- The median ROA for LYRA THERAPEUTICS INC during this period was -51.22%
- LYRA THERAPEUTICS INC reached its highest ROA over the past 5 years at -27.37%.
- The lowest ROA recorded by LYRA THERAPEUTICS INC in the same timeframe -141.22%
LYRA THERAPEUTICS INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for LYRA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Assets [ $ 87.33M ]
(=) ROA [ 0% ] LYRA - Return on Assets, Last 5 years
-141.22%
Minimum
Mar 31, 2025
-27.37%
Maximum
Dec 31, 2020
-68.59%
Average
-51.22%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.44K |
|---|---|
| min | -33.4% |
| max | 33.98% |
| average | 0.12% |
| median | 1.53% |
| std | 10.61% |